X4 Pharmaceuticals Inc (XFOR) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access XFOR Annual Balance Sheets →
The data below summarizes X4 Pharmaceuticals Inc's balance sheet position from Mar 31 2025 to Mar 31 2026, enabling a period-by-period comparison of financial strength.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent216.91
Marketable Securities, Total MA16.81
Cash & Short-term Investments232.00
Accounts receivable1.11
Inventories4.64
Other Current Assets0.00
Prepaid Expense And Other Assets Current2.51
Total Current Assets241.98
Equipment/Property/Plant Net0.15
Goodwill net17.35
Intangible Assets9.06
Other Assets, Noncurrent1.74
Research And Development Incentive Receivable-
Total Assets270.28
Liabilities
Accounts Payable, Current AC5.07
Accrued Liabilities, Current AC17.06
Other Liabilities, Current1.64
Total Current Liabilities23.77
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE0.90
Other liabilities, Noncurrent77.16
Operating Lease Liability Current0.73
Operating Lease Liability Noncurrent-
Total Liabilities101.83
Stockholders' Equity
Common Stock Value0.09
Additional Paid In Capital Common Stock783.27
Retained Earnings / Accumulated Deficit-614.80
Other Equity-0.12
Common Stockholder's Equity168.45
Total Stockholder's Equity168.45
Liabilities & Stockholder's Equity270.28
4 historic quarters locked

Sign in to unlock the full X4 Pharmaceuticals Inc balance sheet history.

About X4 Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001501697-26-000068

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.